. Selection of National Health and Nutrition Examination Survey (NHANES) III study subjects. Shown are the no. of people randomly selected for NHANES III (
) and the subset interviewed ( ) who were considered NHANES III participants. The present study included only n p 39,695 n p 33,994 adults who were examined, had blood obtained by phlebotomy, and for whom remaining serum samples were available. Thus, the final sample size in the present study was 13,894. are therefore a select group. There have been no studies evaluating risk factors for infection in the general US population. Furthermore, studies have used varying HHV-8 assays with differing or uncertain sensitivity and specificity [17, 19] , making comparisons across studies and populations problematic. Thus, further data on the epidemiology of HHV-8 in the United States would be valuable.
In the present study, we used serum samples and data from the National Health and Nutrition Examination Survey (NHANES) III-a large, population-based, cross-sectional study-to study the epidemiology of HHV-8 in the US general adult population. We describe evidence of sexual transmission of this virus among US men.
SUBJECTS AND METHODS
NHANES, which is conducted by the National Center for Health Statistics, US Centers for Disease Control and Prevention, is a series of cross-sectional surveys that provide national statistics on the health and nutritional status of the US noninstitutionalized civilian population through household interviews, standardized physical examinations, and collection of biological samples at special mobile examination centers [20] . NHANES III was conducted during 1988-1994 and included 39,365 individuals randomly sampled through a complex, multistage probability design [20] . Specific subgroups were oversampled, including children, elderly persons, non-Hispanic blacks, and Mexican Americans.
The present article describes data on adults aged 18 years or older from NHANES III (figure 1). Of 19,618 adult NHANES III participants, 17,295 were examined and 16,923 had a phlebotomy performed. We performed HHV-8 antibody testing on 13,894 subjects with available remaining serum samples.
Laboratory methods. HHV-8 antibody testing was performed using EIAs to detect antibodies to the HHV-8 K8.1 structural glycoprotein (expressed during lytic viral replication) and open reading frame (ORF) 73 (also known as latencyassociated nuclear antigen, a viral regulatory protein expressed during latent infection). Serum samples were diluted 1:20 for the K8.1 EIA and 1:100 for the ORF73 EIA. EIA methods have been detailed elsewhere [21] . We measured both K8.1 and ORF73 antibodies because some infected individuals, including those with KS, make antibodies only to lytic or latent antigens [22] .
HHV-8 testing was conducted over a period of 6 months. Quality control criteria determined an acceptable range for variation in the controls, and plates that had control optical density values outside the acceptable range were repeated. Nonetheless, there was noticeable plate-to-plate variability in the EIA optical density results for the positive controls on each plate and, in parallel, in the mean optical density value for samples tested on each plate. To account for this plate-to-plate variability, we adjusted the optical density results for samples by regressing them against the mean optical density of the positive controls on the respective plate. The regression equations were as follows: Laboratory testing for hepatitis B virus (HBV), hepatitis C virus (HCV), herpes simplex virus (HSV)-1, HSV-2, and human papillomavirus (HPV)-16 was performed as described elsewhere [23] [24] [25] [26] [27] . Antibodies to HBV core antigen were detected by radioimmunoassay [25] . Samples were tested for HCV infection with a second-generation EIA and a supplemental test [23] . The presence of HSV-1 and HSV-2 infection was assessed using immunodot assays for viral gG1 and gG2 glycoproteins, respectively [24, 26] . HPV-16 testing, which was limited to participants !60 years old from phase 2 of NHANES III (1991) (1992) (1993) (1994) , was performed using a virus-like particle EIA [27] .
Statistical methods. We examined HHV-8 seroprevalence in the total population and in subgroups of NHANES III subjects. These analyses considered each EIA separately, to account for biological variability in serological responses; for comparison, we also present an overall estimate of seroprevalence based on positivity on either EIA. The primary analyses used the cutoffs chosen on the basis of our regression method, but, in a sensitivity analysis, we also examined seroprevalence based on prior cutoffs.
HHV-8 seroprevalence estimates were weighted according to the NHANES III sampling scheme, to provide unbiased estimates for the total US population and specific demographic subgroups. However, adult NHANES III participants lacking serum samples for our study were older than the included subjects and differed from them by sex and race/ethnicity (data not shown). Because these differences could have introduced bias, we generated a new set of sample weights by poststratifying the standard NHANES III sample weights, so that the new weighted totals by age, sex, and race/ethnicity matched corresponding totals for the US population [28] . All analyses used these new sample weights.
We report HHV-8 seroprevalence data for specific subgroups of NHANES III subjects. Subjects with missing data were excluded. Race/ethnicity was defined as non-Hispanic white, nonHispanic black, and Mexican American; persons not fitting these categories were still included in the total population. We examined HHV-8 seroprevalence according to markers of sexual activity separately for men and women, because preliminary analyses revealed important differences by sex. All participants 17-59 years old were asked questions regarding sexual history in a face-to-face interview. Questioning began with, "At what age did you first have sexual intercourse?" and, for subjects who had had intercourse, "With how many different partners have you ever had sexual intercourse?" Men were further asked how many of these partners were male. We considered MSM activity to be present if a man reported at least 1 male sex partner. We examined seroprevalence according to the duration of sexual activity, lifetime number of sex partners, and MSM activity. Among sexually active adults, the duration of sexual activity (0-20, 21-30, 31-40, and у41 years) was calculated as the current age minus the age at first reported sexual activity. The lifetime number of sex partners was categorized into quartiles (1, 2-4, 5-9, and у10). Finally, we examined HHV-8 seroprevalence according to coinfection with viruses considered to be transmitted sexually (HBV, HSV-2, and HPV-16), sexually or through other intimate contact (HSV-1), and through parenteral exposures such as injection drug use (HCV).
SUDAAN (release 9.0.1; Research Triangle Institute), a statistical package for analyzing complex survey data with multistage sampling, was used for analysis. We calculated seroprevalence estimates and 95% confidence intervals (CIs) on the basis of the logit method. P values for differences in seroprevalence across groups were derived from the Wald F test from logistic regression models. Tests of trend across categories were performed using logistic regression by assigning increasing integer values to increasing levels of the categories. Because we were concerned that small numbers could affect the validity of these P values, we checked them using a quasi-score test [29] , and these agreed. We examined associations with markers of sexual activity separately for men and women, adjusting for age (in 5 categories, treated as an ordinal variable) as a potential confounder.
RESULTS
Using a highly specific assay cutoff, 307 of 13,984 adult subjects were K8.1 seropositive, yielding a seroprevalence estimate of 1.6% (95% CI, 1.4%-1.9%). Likewise, there were 238 individuals who were ORF73 seropositive according to a specific cutoff, yielding similar seroprevalence (1.5% [95% CI, 1.1%-1.8%]). There were 436 individuals seropositive on either assay, corresponding to a seroprevalence of 2.5% (95% CI, 2.2%-3.0%). A total of 109 individuals were seropositive on both assays ( ) . k p 0.39
As noted in Subjects and Methods, in a sensitivity analysis, we also calculated seroprevalence using previous assay cutoffs.
In that approach, the overall seroprevalence was substantially higher (K8.1 seroprevalence, 7.1%; ORF73 seroprevalence, 7.4%).
Demographic patterns in K8.1 and ORF73 seroprevalence are shown in table 1, using the highly specific cutoffs chosen after standardizing EIA results for plate-to-plate variability. K8.1 seroprevalence increased with age, from 0.6% among those 18-30 years old to 2.6% among those у60 years old (P ! ). K8.1 seroprevalence was higher among non-Hispanic .001 blacks (2.1%) and Mexican Americans (2.1%) than among non-Hispanic whites (1.5%). K8.1 seroprevalence decreased with level of education ( ) and, in the comparison of P p .002 marital status, was higher in individuals who were widowed or separated/divorced than in those who were married or never married ( ). K8.1 seroprevalence was also higher in P p .002 individuals living in households with incomes below the US poverty level than in those at or above the poverty level ( ). K8.1 seroprevalence was the same in men and P p .01 women (
) and did not vary by place of birth (table 1) . P p .7 Patterns for ORF73 seroprevalence were similar to those for K8.1 seroprevalence, but differences across subgroups were less distinct and did not reach statistical significance (table 1) .
Data on sexual partnerships were available for 4173 (94.5%) of 4414 men !60 years old. Of these, 69 reported a history of MSM activity (weighted prevalence, 1.9% among all men [95% CI, 1.2%-3.0%]). The median number of reported male partners was 4 (interquartile range, 2-15). K8.1 seroprevalence was substantially higher in this small group of MSM than in men !60 years old who did not report a history of MSM activity (8.2% vs. 1.3%;
). A less-pronounced difference was P p .005 seen in ORF73 seroprevalence (3.3% vs. 1.6%;
). When P p .4 the previous assay cutoffs were used, each assay yielded higher seroprevalence in MSM (25.2% by the K8.1 EIA and 18.4% by the ORF73 EIA).
We next examined patterns in HHV-8 seroprevalence ac- ). These asso-P ! .001 P p .002 ciations remained significant after age adjustment. K8.1 serostatus was not associated with HCV or HPV-16 coinfection.
Among women (table 3), K8.1 seroprevalence did not increase significantly with either duration of sexual activity or lifetime number of sex partners, but seroprevalence was relatively high (4.6%) among the few women reporting no prior sexual activity. The 5 K8.1-seropositive women who reported no prior sexual activity ranged in age from 18 to 59 years, and all were unmarried; 2 were coinfected with HSV-1, but otherwise all were uninfected with the other viruses considered. Overall, K8.1 seroprevalence in women was nonsignificantly elevated in women coinfected with HSV-1 (1.7% vs. 0.9%; ) or HSV-2 (2.0% vs. 1.2%; ) but was not elevated P p .1 P p .1 at all in women coinfected with HBV (1.6% vs. 1.5%;
). P p .9 K8.1 serostatus was not associated with HCV or HPV-16 coinfection.
To some extent, patterns in ORF73 seroprevalence for men and women mirrored those for K8.1 seroprevalence, although they were less pronounced (tables 2 and 3). In men, ORF73 seroprevalence was lower in HCV-infected subjects than in uninfected subjects ( ), but this association was not sig-P p .02 nificant in women. In both men and women, ORF73 seroprevalence was positively associated with HBV coinfection (4.8% vs. 
DISCUSSION
To our knowledge, the present study is the first to systematically evaluate the epidemiology of HHV-8 in the general US population. We used 2 different assays to independently measure antibodies to HHV-8 proteins expressed in lytic or latent infection. An important finding was the association between HHV-8 serostatus and markers of sexual risk behaviors among men. As expected, we found that HHV-8 infection was especially frequent among MSM (when highly specific assay cutoffs were used: K8.1 seroprevalence, 8.6%; ORF73 seroprevalence, 3.4%). Among MSM, HHV-8 seroprevalence increases with the number of previous male partners [4] [5] [6] 30] , but the particular acts responsible for HHV-8 transmission among MSM are uncertain [31] . HHV-8 seroprevalence was noticeably lower among MSM in our study than in prior studies (20%-60%) [4-6, 9, 30] . A likely explanation is the high specificity of the assay cutoffs that we relied on. Indeed, HHV-8 seroprevalence in MSM was materially higher when we used our prior cutoffs. Another explanation could be the recruitment of men in NHANES III from the general population. Thus, MSM in our study had had relatively few male partners (e.g., a median of 4 lifetime partners among NHANES MSM vs. a median of 6-10 partners during the preceding 2 years among MSM in the study by Martin et al. [4] ). Likewise, men in the general population who report MSM activity may engage in less-risky types of behavior than those considered typical for MSM in prior studies (e.g., attendance at "bath houses" or the use of stimulant drugs). Even among US males who did not admit to prior MSM activity, HHV-8 seroprevalence was positively associated with markers of sexual activity, such as the lifetime number sex partners and coinfection with the sexually transmitted viruses HBV, HSV-1, and HSV-2. These associations might arise because of the heterosexual transmission of HHV-8 to men. However, it is equally plausible that our findings reflect unreported MSM activity. In NHANES III, questions regarding sexual activity were asked in a face-to-face interview, and the proportion of men who reported prior sexual activity with other men (1.9%
[95% CI, 1.2%-3.0%]) was lower than suggested by recent surveys (4.7%) [32] . It is therefore not possible to rule out that underreporting of MSM activity by NHANES III males accounts for the observed associations with markers of sexual activity among men.
Interestingly, we did not find evidence that HHV-8 seroprevalence was associated with these same markers of sexual activity among women. Both women and men could have underreported their sexual history, which might have obscured an association with sexual transmission. Nonetheless, HHV-8 was only weakly associated with HSV-2 in female subjects, even though HSV-2 is sexually transmitted and a clear relationship between HSV-2 and sexual history is present in women in NHANES III [24] .
Existing data on heterosexual transmission of HHV-8 are inconclusive. One prior study of male and female attendees at a sexually transmitted disease clinic found no association between HHV-8 infection and number of recent partners [9] . Studies of HIV-infected men and prostitutes also have provided no evidence for heterosexual transmission of HHV-8 [7] [8] [9] 33] , although the studies were limited by small size. Interestingly, in 2 high-risk cohorts of US women, HHV-8 serostatus was positively associated with HIV infection and a history of other sexually transmitted infections but was not related to the lifetime number of male sex partners or prior sex with a bisexual man [10, 34] . In support of heterosexual transmission of HHV-8 to US women, KS risk is especially high among HIV-infected women who acquire HIV (and, presumably, HHV-8) from a bisexual man [35] .
Ways by which HHV-8 could be transmitted sexually are uncertain. HHV-8 is frequently shed in saliva from infected individuals [11] , raising the possibility of direct oral transmission (e.g., by kissing). Among homosexual men, HHV-8 infection is strongly associated with a recent history of oral or anal sex [5, 30] , which may involve contact of saliva with the insertive partner's penis. Given the associations that we observed with markers of sexual activity among men but not women, it is possible that HHV-8 is spread heterosexually to men through similar acts between a man and his infected female sex partner.
We also observed differences in HHV-8 seroprevalence by race/ethnicity, education level, marital status, and household income. The elevated seroprevalence among blacks and Mexican Americans and among those with lower education level and household income could reflect environmental conditions (e.g., crowding and inadequate nutrition) associated with lower socioeconomic status and conducive to HHV-8 transmission by as-yet-undefined mechanisms [36] . HHV-8 is transmitted within families in areas of high endemicity [37] , and such transmission might occur in the United States as well.
Each HHV-8 assay separately yielded an overall estimate of 1.5%-1.6% seroprevalence in US adults and, considering the presence of antibodies on either assay to indicate infection, provided an upper estimate of 2.5%. Although the presence of antibody to HHV-8 might thus appear to be somewhat uncommon, we are reluctant to emphasize this result as an estimate of the prevalence of HHV-8 infection among US adults. A general limitation of studies of the epidemiology of HHV-8 is the lack of a standard serological assay for infection. We deliberately chose cutoffs for the EIAs that yielded a high predictive value for positive results. In the end, this approach was supported by the demonstration of clear associations of K8.1 antibody results with demographic and sexual risk factors. Also, although the results with the ORF73 EIA were less definitive, the level of agreement between the 2 assays appeared to be reasonable ( ). However, our approach to standardizing k p 0.39 optical density measurements across plates has not been validated, and we could have underestimated the prevalence of infection. A sensitivity analysis using an alternative approach for determining seropositivity, with our previous cutoffs, yielded substantially higher seroprevalence estimates. However, we did not rely on this analysis, because it did not fully account for the observed plate-to-plate variability in EIA results and because the specificity (and thus the false-positive rate) was uncertain.
An additional limitation is that the seroprevalence estimates and associations for some groups (e.g., HCV-infected individuals) were based on small numbers of NHANES III subjects. Although the CIs and P values reflect the statistical uncertainty, we caution against overinterpreting these results. Finally, NHANES III lacks data on sexual practices, which prevented us from exploring potential routes of sexual transmission in more detail.
In conclusion, our study provides population-based epidemiological data about the determinants of HHV-8 serostatus in US adults. Our results suggest that HHV-8 infection is increased in relation to markers of sexual activity among men.
